Dexcom INC 10-Q quarterly reports

DexCom, Inc. announced its second quarter 2026 financial results, showcasing a 13% increase in revenue to $1.31 billion and a significant 50% rise in operating income.

DexCom reported strong Q1 2026 growth with $1.19 billion in revenue and a 91% increase in operating income compared to the prior year.

Dexcom reports strong third-quarter 2025 financial results with significant revenue and net income growth, alongside new product clearances and an ongoing share repurchase program.

Dexcom, a leader in continuous glucose monitoring systems, announced robust second-quarter financial results with significant revenue and net income growth, while addressing ongoing regulatory challenges and market pricing pressures.

Dexcom's Q1 2025 revenue increased by 12% year-over-year, while net income decreased due to higher income tax expenses.

Dexcom's third-quarter results show a slight revenue increase but a decrease in profitability, alongside ongoing legal challenges and strategic adjustments.

Dexcom's second quarter 2024 results show a 15% increase in revenue year-over-year, driven by growth in its customer base and disposable sensor sales.

Dexcom's first quarter 2024 results show significant growth in revenue and net income, driven by increased sales volume of their continuous glucose monitoring systems.